NeuroBo Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 cli…

Biotechnology
US, Boston [HQ]

Income Statements

Loading...
End of NRBO's Analysis
CIK: 1638287 CUSIP: 64132R107 ISIN: US64132R4048 LEI: - UEI: -
Secondary Listings
NRBO has no secondary listings inside our databases.